Showing results (1461-1470 of 9,979) with videos related to

Sort By:
Pageof 998
Leukemia & Lymphoma|January 11, 2019
ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patientsAndrea Mareckova, Jitka Malcikova, Nikola Tom, et al.
Leukemia & Lymphoma|January 11, 2019
Plasma asparaginase activity and asparagine depletion in acute lymphoblastic leukemia patients treated with pegaspargase on Children's Oncology Group AALL07P4.Reuven J Schore, Meenakshi Devidas, Archie Bleyer, et al.
Leukemia & Lymphoma|January 12, 2019
Rural and urban patients with diffuse large B-cell and follicular lymphoma experience reduced overall survival: a National Cancer DataBase studyAndrew J Ritter, Jordan S Goldstein, Amy A Ayers, et al.
Leukemia & Lymphoma|January 12, 2019
Obinutuzumab plus chemotherapy followed by obinutuzumab monotherapy is cost-effective vs. rituximab plus chemotherapy followed by rituximab monotherapy for previously untreated follicular lymphoma patients in the United StatesGregory F Guzauskas, Anthony Masaquel, Per-Olof Thuresson, et al.
Leukemia & Lymphoma|January 12, 2019
Asparaginase treatment in infants with acute lymphoblastic leukemia; pharmacokinetics and asparaginase hypersensitivity in Interfant-06Birgitte Klug Albertsen, Arja Harila-Saari, Kirsi Jahnukainen, et al.
Leukemia & Lymphoma|November 15, 2019
Loss of the Y chromosome predicts a high relapse risk in younger adult male patients with t(8;21) acute myeloid leukemia on high-dose cytarabine consolidation therapy: a retrospective multicenter studyWei Zhou, Guofeng Chen, Dan Gong, et al.
Leukemia & Lymphoma|July 26, 2021
Disease heterogeneity, prognostication and the role of targeted therapy in multiple myelomaSaurabh Zanwar, Shaji Kumar
Leukemia & Lymphoma|July 15, 2021
The promising outcome with simultaneous integrated boost intensity modulated radiotherapy in confined nasal extranodal NK/T-cell lymphomaYuzhi Song, Jing Li, Shuoshuo Wang, et al.
Leukemia & Lymphoma|July 7, 2021
Functional expression of aryl hydrocarbon receptor as a potential novel therapeutic target in human multiple myelomaTiffany Hughes, Francesca Cottini, Evan Catton, et al.
Leukemia & Lymphoma|December 7, 2020
Prognostic factors affecting survival in children and adolescents with HIV and Hodgkin lymphoma in South AfricaJennifer Ann Geel, Katherine Claire Eyal, Marc Gerald Hendricks, et al.
Pageof 998